Table 3.
Data about patient and graft survival, patient compliance and complications concerning educational and vocational status in liver transplant recipients
| ES | VS | |||||
|---|---|---|---|---|---|---|
| Low (n=201) | High (n=77) | p | Low (n=211) | High (n=67) | p | |
| Graft failure (%/n) | 18.9 (38) | 20.8 (16) | 0.724 | 19.9 (42) | 17.9 (12) | 0.719 |
| Clinical | 3.0 (6) | 6.5 (5) | 0.180 | 3.8 (8) | 4.5 (3) | 0.730 |
| Pathologic | 8.5 (17) | 11.7 (9) | 0.408 | 8.5 (18) | 11.9 (8) | 0.404 |
| Clinicopathologic | 22.4 (45) | 23.4 (18) | 0.860 | 23.7 (50) | 19.4 (13) | 0.465 |
| Death (%/n) | 9.0 (18) | 6.5 (5) | 0.505 | 9.5 (20) | 4.5 (3) | 0.195 |
| Died >100 days | 10.0 (20) | 7.8 (6) | 0.580 | 10.0 (21) | 7.5 (5) | 0.542 |
| Cause of death (%/n) | 7.0 (14) | 5.2 (4) | 0.787 | 7.6 (16) | 3.0 (2) | 0.258 |
| Infection | 2.5 (5) | 3.9 (3) | 0.689 | 2.8 (6) | 3.0 (2) | 1.000 |
| Cardiac | 3.0 (6) | 6.5 (5) | 0.184 | 3.3 (7) | 6.0 (4) | 0.332 |
| Respiratory | 70.6 (142) | 61.0 (47) | 0.124 | 70.1 (148) | 61.2 (41) | 0.171 |
| Other | 15.9 (32) | 6.5 (5) | 0.038 | 15.2 (32) | 7.5 (5) | 0.106 |
| Patient incomplian t(%/n) | 44.8 (90) | 33.8 (26) | 0.096 | 45.0 (95) | 31.3 (21) | 0.048 |
| Drugs | 22.9 (46) | 16.9 (13) | 0.273 | 21.8 (46) | 19.4 (13) | 0.676 |
| Visits | 21.9 (44) | 16.9 (13) | 0.355 | 23.2 (49) | 11.9 (8) | 0.046 |
| <24months | 27.9 (56) | 22.1 (17) | 0.327 | 26.1 (55) | 26.9 (18) | 0.897 |
| >24months | 16.9 (34) | 11.7 (9) | 0.281 | 19.0 (40) | 4.5 (3) | 0.004 |
| 1visit | 49.3 (99) | 46.8 (36) | 0.709 | 47.9 (101) | 50.7 (34) | 0.681 |
| ≥2visits | 41.8 (84) | 40.3 (31) | 0.817 | 40.8 (86) | 43.3 (29) | 0.715 |
| Lifestyle weight | 11.4 (23) | 10.4 (8) | 0.803 | 11.4 (24) | 10.4 (7) | 0.834 |
| Smoking | 3.0 (6) | 6.5 (5) | 0.184 | 2.8 (6) | 7.5 (5) | 0.091 |
| Alcohol | 87.1 (175) | 87.0 (67) | 0.991 | 85.8 (181) | 91.0 (61) | 0.264 |
| Complications (%/n) | 16.9 (34) | 18.2 (14) | 0.803 | 16.6 (35) | 19.4 (13) | 0.595 |
| Surgical | 58.2 (117) | 62.3 (48) | 0.531 | 57.3 (121) | 65.7 (44) | 0.227 |
| Metabolic | 18.9 (38) | 23.4 (18) | 0.406 | 19.4 (41) | 22.4 (15) | 0.599 |
| Neurologic | 24.9 (50) | 24.7 (19) | 0.972 | 26.1 (55) | 20.9 (14) | 0.393 |
| Cardiac | 64.7 (130) | 59.7 (46) | 0.445 | 64.0 (135) | 61.2 (41) | 0.680 |
| Infection | 7.5 (15) | 9.1 (7) | 0.653 | 7.1 (15) | 9.0 (6) | 0.618 |
| Neoplasia | 64.7 (130) | 58.4 (45) | 0.335 | 64.5 (136) | 58.2 (39) | 0.356 |
| Other | 21.4 (43) | 22.1 (17) | 0.901 | 22.7 (48) | 17.9 (12) | 0.402 |
| Vascular | 57.7 (116) | 53.2 (41) | 0.502 | 58.3 (123) | 50.7 (34) | 0.278 |
| GIS | 5.0 (10) | 6.5 (5) | 0.566 | 5.7 (12) | 4.5 (3) | 1.000 |
| Rheumatologic | 20.4 (41) | 18.2 (14) | 0.678 | 19.4 (41) | 20.9 (14) | 0.793 |
| Biliary | 10.0 (20) | 7.8 (6) | 0.580 | 10.0 (21) | 7.5 (5) | 0.542 |
| Incisional hernia (%/n) | 60.7 (122) | 51.9 (40) | 0.186 | 59.2 (125) | 55.2 (37) | 0.448 |
| Less work act. (%/n) | 42.5±25.8 (months) | 45.2±26.9 (months) | 0.369 | 42.7±26.3 (months) | 44.9±25.5 (months) | 0.525 |
| Follow up (days/months) (mean±SD) | 1275.3±775.1 (days) | 1357.0±808.0 (days) | 0.372 | 1281.7±790.5 (days) | 1348.9±765.6 (days) | 0.525 |
| Primary (%/n) recurrent disease | 10.0 (20) | 18.2 (14) | 0.061 | 10.4 (22) | 17.9 (12) | 0.103 |
| Post-transplant(%/n) serology(+) continue | 12.4 (25) | 18.2 (14) | 0.217 | 12.1 (27) | 22.2 (12) | 0.053 |
| Immunosup (%/n). | 10.4 (21) | 13.0 (10) | 0.547 | 10.4 (22) | 13.4 (9) | 0.496 |
| ineffective/adv. eff | 8.0 (16) | 3.9 (3) | 0.229 | 7.6 (16) | 4.5 (3) | 0.579 |
| Reperfusion synd. Preservation damage | 3.5 (7) | 2.6 (2) | 1.000 | 3.8 (8) | 1.5 (1) | 0.692 |